iBio Announces Issuance of U.S. Patent Covering Endostatin Peptides for Treating Fibrosis

The Company is developing such a molecule as IBIO-100 for the treatment of fibrotic disorders, including systemic scleroderma and idiopathic pulmonary fibrosis.